Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Glycinate vs Metformin Hydrochloride in T2D
NCT04943692Phase 3Suspended
- Sponsor
- Laboratorios Silanes
- Start
- Aug 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Metformin glycinate in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Laboratorios Silanes. Primary endpoint: Change in HbA1c at 12 months. Started Aug 2021; status: suspended.
02
Drugs
Metformin glycinate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04943692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04943692.